Morgens Waterfall Vintiadis & CO Inc Heron Therapeutics, Inc. Transaction History

Morgens Waterfall Vintiadis & CO Inc

  • $118 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$10.23 - $24.56 $511,500 - $1.23 Million
-50,000 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$17.42 - $26.61 $191,620 - $292,710
11,000 Added 28.21%
50,000 $1.18 Million
Q2 2018

Aug 14, 2018
BUY
$26.4 - $42.0 $1.03 Million - $1.64 Million
39,000 New
39,000 $1.52 Million

Others Institutions Holding HRTX

# of Institutions
176
Shares Held
121M
Call Options Held
80.4K
Put Options Held
94.9K
View Full List

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $210M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Morgens Waterfall Vintiadis & CO Inc Portfolio

Follow Morgens Waterfall Vintiadis & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgens Waterfall Vintiadis & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Morgens Waterfall Vintiadis & CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email